MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Cross-Linked Ionic Core Micelles for Efficient Delivery of Therapeutics

University of Nebraska Medical Center / UNeMed Corporation
Novel micelles by creating amphiphilic block copolymers...

Mechanism of action

Drug Delivery

Full description

Summary
Micelles are often used for drug delivery; however, there is a need for improved compositions Researchers at The University of Nebraska Medical Center have developed novel micelles by creating amphiphilic block copolymers that have a large solubility difference between the hydrophilic and hydrophobic blocks that assemble in aqueous solutions into polymer micelles of nanoscale size. The micelles can be used to encapsulate drugs or biological agents for improved delivery of the therapeutic agent. The novel micelle composition combines several structural features which improve the micelle’s capacity for drug delivery as compared to existing polymer micelle drug delivery compositions.

Market Value
Use in hospitals world-wide for improvment of drug delivery. May be used widely in cancer research/treatment.


Features and Benefits

  • Improved Therapeutic Index
  • Increased Stability and Solubility
  • Wide Range of Deliverable Biological Agents
  • Increased Bioavailability
  • Permeable to Membranes and Biological Barriers

Development status

Early Stage

Patent information

Application Published (US-2004-228823-A1)

(TID - 28)

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with the University of Nebraska Medical Center.

Licensing contact

Technology Inquiries
Technology

Contact directly

Company details

University of Nebraska Medical Center / UNeMed Corporation

Technology Marketing and Licensing for The University of Nebraska Medical Center

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us